Delhaize Group Issues Preliminary First Quarter 2013

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Delhaize Group Issues Preliminary First Quarter 2013 Results and Postpones Capital Markets Day

BRUSSELS, BELGIUM--(Marketwired - Apr 22, 2013) - Delhaize Group (Euronext Brussels: DELB, NYSE: DEG), the Belgian international food retailer, announces preliminary unaudited figures for the first quarter of 2013 and its decision to postpone its Capital Markets Day.

» First Quarter 2013 Results (based on preliminary unaudited figures)

In the first quarter of 2013, Delhaize Group's revenues were EUR5.5 billion, an increase of 2.1% and 1.5% at identical and actual exchange rates, respectively. Organic revenue growth (excluding revenues from the 126 stores and 45 stores closed in the U.S. in Q1 2012 and Q1 2013 respectively) was 3.8%. In the U.S., comparable store sales growth was 1.9% (3.0% including a +1.1% calendar impact), fueled by favorable weather conditions and continued good volume trends in the Food Lion repositioned stores and at Hannaford. This was partly offset by deflation which was however at a lower level than the previous quarter. In Belgium, comparable store sales growth was 2.4% (0.6% including a -1.8% calendar impact) as a result of inflation and improved volume trends. In Southeastern Europe, revenues grew by 6.8% at identical exchange rates due to store openings, while consumer spending is under pressure in the region.

Underlying operating profit was EUR214 million, a 13.7% increase compared to the first quarter of 2012 at identical exchange rates (+13.0% at actual exchange rates) resulting in an underlying operating margin of 3.9% (3.5% in Q1 last year). In the U.S., underlying operating margin was 4.2% (3.7% in Q1 last year) as a result of positive sales leverage supported by the favorable calendar impact, non-performing store closures, cost reductions and Bottom Dollar Food's significantly improved results. This was partly offset by continued price investments. In Belgium, underlying operating margin was 5.1% (4.6% in Q1 last year), mostly driven by cost control and positive sales leverage. In Southeastern Europe, underlying operating margin decreased to 1.4% (2.0% last year), mostly driven by price investments.

Underlying EBITDA of EUR369 million represented a 7.1% increase compared to the first quarter of 2012 at identical exchange rates (+6.4% at actual exchange rates).

Free cash flow reached EUR255 million (EUR87 million in Q1 2012) due to higher EBITDA, working capital improvements and continued capital discipline.

Full first quarter results will be disclosed on May 8, 2013 as initially scheduled, including a normally scheduled conference call with management.

» 2013 Outlook

As a consequence of our continued focus on our strategic priorities, Delhaize Group expects underlying operating profit of approximately EUR775 million for the full year 2013 at identical exchange rates.

» Postponement of Capital Markets Day

Delhaize Group announces the decision to postpone its Capital Markets Day, previously scheduled for May 8, 2013, until later in the year. This will allow the Company to provide a more comprehensive update on its business and long-term strategy.

» Delhaize Group

Delhaize Group is a Belgian international food retailer present in ten countries on three continents. At the end of 2012, Delhaize Group's sales network consisted of 3 451 stores. In 2012, Delhaize Group posted EUR22.6 billion ($29.0 billion) in revenues and EUR104 million ($134 million) in net profit (Group share). At the end of 2012, Delhaize Group employed approximately 158 000 people. Delhaize Group's stock is listed on NYSE Euronext Brussels (DELB) and the New York Stock Exchange (DEG).

This press release is available in English, French and Dutch. You can also find it on the website http://www.delhaizegroup.com . Questions can be sent to investor@delhaizegroup.com .

Press release in pdf format: http://hugin.info/133961/R/1694636/557386.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Delhaize Group via Thomson Reuters ONE

[HUG#1694636]

Contacts Investor Relations: +32 2 412 21 51 Media Relations: +32 2 412 86 69

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 50

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 29

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 48

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 40

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 41

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 40

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 45

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Economic Indicators Shaping Financial Markets This Week

Updated Category News Views 84

Key Economic Indicators Impacting Financial Markets This Week As traders prepare for another important trading day, there’s a significant emphasis on crucial decisions and economic data releases that are expected to sway market trends. Particularly, the Manufacturing and Services PMI reports are critical indicators of current economic conditions and business sentiment....

Continue Reading
Innovative Alliance Launched for Sustainable Aviation Fuel Production

Updated Category News Views 230

Innovative Alliance for Sustainable Aviation Fuel In a forward-thinking move, industry leaders Honeywell (NASDAQ: HON), Johnson Matthey, GIDARA Energy, and SAMSUNG E&A have united to form a strategic technology alliance aimed at revolutionizing the production of Sustainable Aviation Fuel (SAF). This collaboration focuses on converting biomass and municipal solid waste...

Continue Reading
Pfizer's Strategy to Strengthen Bid for Metsera Amid Rivalry

Updated Category News Views 144

Pfizer's Bold Move in the Metsera Acquisition Battle The Delaware Chancery Court recently ruled against Pfizer Inc. (NYSE: PFE), rejecting its request for a temporary restraining order aimed at blocking Metsera, Inc. (NASDAQ: MTSR) from terminating its merger agreement with Pfizer in light of a competing proposal from Novo Nordisk A/S (NYSE: NVO). Pfizer's Response to the...

Continue Reading
Innovative Garden Movement Highlighted in Film Premiere

Updated Category News Views 349

Film Premiere Celebrates Gardening Activism Miranda Winters and Rocky Romano are excited to announce a significant event that stands out in the film industry—a premiere of their thought-provoking short film, "Gangsta Gardener." This highly anticipated event will take place at the prestigious Hammer Museum, an influential cultural institution representing creativity and...

Continue Reading
SineuGene Advances Gene Therapy for ALS into Global Trials

Updated Category News Views 267

Exciting Developments in Gene Therapy for ALS SineuGene Therapeutics Co., Ltd., a pioneering clinical-stage biotechnology company, recently achieved a significant milestone in the development of innovative treatments for amyotrophic lateral sclerosis (ALS). The company has secured clearance for its Investigational New Drug (IND) application for SNUG01, a novel gene...

Continue Reading